Policy & Advocacy MassBio Statement on President Trump’s executive order on drug pricing Apr 16, 2025
Policy & Advocacy The Commonwealth’s unwavering commitment to science, research, and therapies Apr 07, 2025
Policy & Advocacy MassBio comments on termination of billions of dollars in indirect NIH funding Feb 10, 2025
Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Policy & Advocacy Post-Election Healthcare and Biotech Outlook: Implications for Massachusetts and Beyond Dec 05, 2024
Policy & Advocacy MassBio Op-Ed in STAT: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma Sep 12, 2024
